BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 23325075)

  • 1. Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease?
    Wheeler DC; Becker GJ
    Kidney Int; 2013 Mar; 83(3):377-83. PubMed ID: 23325075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for the management of blood pressure in CKD.
    Ruzicka M; Quinn RR; McFarlane P; Hemmelgarn B; Ramesh Prasad GV; Feber J; Nesrallah G; MacKinnon M; Tangri N; McCormick B; Tobe S; Blydt-Hansen TD; Hiremath S
    Am J Kidney Dis; 2014 Jun; 63(6):869-87. PubMed ID: 24725980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary on the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in CKD.
    Mann JFE; Chang TI; Cushman WC; Furth SL; Ix JH; Hou FF; Knoll GA; Muntner P; Pecoits-Filho R; Sarnak MJ; Tomson CRV; Craig JC; Tunnicliffe DJ; Howell M; Tonelli M; Cheung M; Earley A; Cheung AK
    Curr Cardiol Rep; 2021 Aug; 23(9):132. PubMed ID: 34398316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KDOQI US commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD.
    Sarnak MJ; Bloom R; Muntner P; Rahman M; Saland JM; Wilson PW; Fried L
    Am J Kidney Dis; 2015 Mar; 65(3):354-66. PubMed ID: 25465166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the KDIGO Systolic Blood Pressure Target <120 mm Hg for Chronic Kidney Disease Appropriate in Routine Clinical Practice?
    Dasgupta I; Zoccali C
    Hypertension; 2022 Jan; 79(1):4-11. PubMed ID: 34784720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease.
    Cheung AK; Chang TI; Cushman WC; Furth SL; Hou FF; Ix JH; Knoll GA; Muntner P; Pecoits-Filho R; Sarnak MJ; Tobe SW; Tomson CRV; Lytvyn L; Craig JC; Tunnicliffe DJ; Howell M; Tonelli M; Cheung M; Earley A; Mann JFE
    Kidney Int; 2021 Mar; 99(3):559-569. PubMed ID: 33637203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canadian Society of Nephrology commentary on the KDIGO clinical practice guideline for CKD evaluation and management.
    Akbari A; Clase CM; Acott P; Battistella M; Bello A; Feltmate P; Grill A; Karsanji M; Komenda P; Madore F; Manns BJ; Mahdavi S; Mustafa RA; Smyth A; Welcher ES
    Am J Kidney Dis; 2015 Feb; 65(2):177-205. PubMed ID: 25511161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spanish Society of Nephrology document on KDIGO guidelines for the assessment and treatment of chronic kidney disease.
    Gorostidi M; Santamaría R; Alcázar R; Fernández-Fresnedo G; Galcerán JM; Goicoechea M; Oliveras A; Portolés J; Rubio E; Segura J; Aranda P; de Francisco AL; Del Pino MD; Fernández-Vega F; Górriz JL; Luño J; Marín R; Martínez I; Martínez-Castelao A; Orte LM; Quereda C; Rodríguez-Pérez JC; Rodríguez M; Ruilope LM
    Nefrologia; 2014 May; 34(3):302-16. PubMed ID: 24798565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.
    Inker LA; Astor BC; Fox CH; Isakova T; Lash JP; Peralta CA; Kurella Tamura M; Feldman HI
    Am J Kidney Dis; 2014 May; 63(5):713-35. PubMed ID: 24647050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A European Renal Best Practice (ERBP) position statement on the Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for the management of blood pressure in non-dialysis-dependent chronic kidney disease: an endorsement with some caveats for real-life application.
    Verbeke F; Lindley E; Van Bortel L; Vanholder R; London G; Cochat P; Wiecek A; Fouque D; Van Biesen W
    Nephrol Dial Transplant; 2014 Mar; 29(3):490-6. PubMed ID: 24071661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suboptimal blood pressure control in chronic kidney disease stage 3: baseline data from a cohort study in primary care.
    Fraser SD; Roderick PJ; McIntyre NJ; Harris S; McIntyre CW; Fluck RJ; Taal MW
    BMC Fam Pract; 2013 Jun; 14():88. PubMed ID: 23800117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Blood Pressure in CKD.
    Drawz PE; Beddhu S; Bignall ONR; Cohen JB; Flynn JT; Ku E; Rahman M; Thomas G; Weir MR; Whelton PK
    Am J Kidney Dis; 2022 Mar; 79(3):311-327. PubMed ID: 35063302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Blood Pressure in Patients With Chronic Kidney Disease Not Receiving Dialysis: Synopsis of the 2021 KDIGO Clinical Practice Guideline.
    Tomson CRV; Cheung AK; Mann JFE; Chang TI; Cushman WC; Furth SL; Hou FF; Knoll GA; Muntner P; Pecoits-Filho R; Tobe SW; Lytvyn L; Craig JC; Tunnicliffe DJ; Howell M; Tonelli M; Cheung M; Earley A; Ix JH; Sarnak MJ
    Ann Intern Med; 2021 Sep; 174(9):1270-1281. PubMed ID: 34152826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Cheung AK; Chang TI; Cushman WC; Furth SL; Ix JH; Pecoits-Filho R; Perkovic V; Sarnak MJ; Tobe SW; Tomson CRV; Cheung M; Wheeler DC; Winkelmayer WC; Mann JFE;
    Kidney Int; 2019 May; 95(5):1027-1036. PubMed ID: 31010478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD.
    Taler SJ; Agarwal R; Bakris GL; Flynn JT; Nilsson PM; Rahman M; Sanders PW; Textor SC; Weir MR; Townsend RR
    Am J Kidney Dis; 2013 Aug; 62(2):201-13. PubMed ID: 23684145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What Is Wrong with the Blood Pressure Target Recommendation of KDIGO 2021 for Hypertension in Chronic Kidney Disease?
    Jamale T; Kulkarni M; Keskar V
    Nephron; 2023; 147(10):616-620. PubMed ID: 37231907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggressive blood pressure reduction and renin-angiotensin system blockade in chronic kidney disease: time for re-evaluation?
    Sarafidis PA; Ruilope LM
    Kidney Int; 2014 Mar; 85(3):536-46. PubMed ID: 24048382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline.
    Stevens PE; Levin A;
    Ann Intern Med; 2013 Jun; 158(11):825-30. PubMed ID: 23732715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential implications of the 2021 KDIGO blood pressure guideline for adults with chronic kidney disease in the United States.
    Foti KE; Wang D; Chang AR; Selvin E; Sarnak MJ; Chang TI; Muntner P; Coresh J
    Kidney Int; 2021 Mar; 99(3):686-695. PubMed ID: 33637204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension control and antihypertensive therapy in patients with chronic kidney disease.
    Unni S; White K; Goodman M; Ye X; Mavros P; Bash LD; Brixner D
    Am J Hypertens; 2015 Jun; 28(6):814-22. PubMed ID: 25421796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.